Data from a 5-year open-label treatment period on the safety profile of erenumab (Aimovig) showed the treatment helped patients with episodic migraine achieve a sustained reduction in the number of monthly migraine days and the number of days in which therapies were needed for acute migraines.
With the virtual format of this year’s Academy of Managed Care Pharmacy (AMCP) Nexus 2020, there will be several sessions and novel features to look out for, including networking events, educational programming, and a keynote speech.
Tele–intensive care units (ICUs) address coverage gaps and improve quality outcomes, noted John Kazianis, MD, clinical associate professor, Yale School of Medicine, and medical director, InSight Tele-ICU, Yale New Haven Hospital.
Results from a national survey conducted by the Association of Diabetes Care & Education Specialists show that individuals living with diabetes feel they are doing everything they can to manage the condition, yet believe more can be done.
Pfizer will not apply for emergency use authorization of its coronavirus disease 2019 (COVID-19) vaccine until at least mid-November; infectious disease experts warn of a potential third wave of COVID-19; rates of major depression increased among millennials.
Atopic dermatitis (AD) has a negative impact on quality of life, and the burden of this disease in adolescents and their parents should be taken into account as part of the management of AD.
The launch comes as major cancer research organizations are calling for ways to increase diversity in clinical trials.
Pediatricians and pediatric HIV specialists need to coordinate their care plans for infants born with potential perinatal exposure to the virus, according to a new report from the American Academy of Pediatrics.
Although probing for congenital nasolacrimal duct obstruction is safe and effective , age at the time of initial intervention and bilateral surgery constitutes a significant risk for a failed procedure, according to study results published in BMC Ophthalmology.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Analyzing data from a phase 2 study of patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA,) researchers found that the assessment is a valid, reliable, and responsive assessment of motor function ability for these patients.
In assessing symptoms of Parkinson disease exacerbated by the coronavirus disease 2019 (COVID-19) pandemic, nonmotor neuropsychiatric and automatic symptoms were noted to particularly affect both patients and their respective caregivers.
Nearly 10,000 deaths from non–small-cell lung cancer (NSCLC) were likely delayed between 2014 to 2016, the researchers calculated.
Using the Framingham risk score to differentiate patients with psoriatic arthritis with and without coronary artery disease can underestimate cardiovascular risks in these patients.
Patients with heart failure should be classified as high risk in light of the coronavirus disease 2019 (COVID-19) pandemic; they are thought to be more susceptible to the virus.
Results from a large international survey indicated that depression worsened the systemic symptom burden for patients.
Inconsistent sleep was found to be significantly associated with inflammatory dysfunction, particularly in women, according to study findings.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
The FDA strengthens its guidance for pain reliever use in pregnant women; the United States sees its greatest increase in coronavirus disease 2019 (COVID-19) cases since August; studies point to association of blood type and COVID-19 risk.
Prompted by students, the medical school overturned a longstanding diagnostic protocol that was not well-founded in evidence.
This week, the top managed care news included the first case of COVID-19 reinfection in the United States; a positive side to halting trials to evaluate vaccine safety; a rise in employer-sponsored health insurance premiums for 2020.
New data estimates from the Global Burden of Disease Study published by The Lancet illustrate how rising rates of chronic disease and public health failures compounded over decades to worsen the coronavirus disease 2019 (COVID-19) pandemic.
Interactive technology plays an ever-increasing role in our everyday lives, so it only makes sense that this rapidly improving technology is making its way other areas of our lives, including health care.
Differences in clinical and demographic characteristics between men and women with multiple sclerosis (MS) are more prevalent regarding disease course than they are when stratifying by sex.
Michael S. Fitts, assistant dean for user access and diversity for The University of Alabama at Birmingham, speaks on his experience with early-onset Parkinson disease and the challenges and misconceptions associated with the condition.
A recent study of persons with HIV shows that their HIV infection was not associated with progression of subclinical atherosclerosis.
A preview of some of the topics that will appear at next week’s Academy of Managed Care Pharmacy (AMCP) Nexus 2020 meeting, which will be held virtually.
Wildfire smoke contributes to an uptick in emergency department visits; President Donald Trump holds a rally in Iowa; FDA approves first ebola treatment.
Based on the findings, the researchers are arguing that minimal residual disease (MRD) should be considered as a clinical trial endpoint.
Patients with chronic heart failure and comorbid mental/behavioral disorders or diabetes had worse quality of life (QOL), according to a recent literature review.